OPRX — OptimizeRx Corp
—
Nasdaq ·
Industrials ·
Professional Services ·
CIK 1448431 ·
Last close
$5.23
Market Cap
$98.14M
52W High
$8.26
52W Low
$4.57
ADV30
466,767
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 19,844,000 | 14,932,000 | 396,000 | -495,000 | 167,264,000 | 20,169,000 | 37,653,000 |
| Dec 2025 | 32,239,000 | 24,100,000 | 8,937,000 | 5,020,000 | 176,918,000 | 23,365,000 | 48,624,000 |
| Sep 2025 | 26,067,000 | 17,516,000 | 2,050,000 | 779,000 | 170,321,000 | 19,519,000 | 48,058,000 |
| Jun 2025 | 29,195,000 | 18,635,000 | 3,189,000 | 1,532,000 | 169,265,000 | 16,585,000 | 49,981,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$14,384,000
Investing CF
$131,000
Financing CF
$-10,919,000
CapEx
$-159,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$0.35
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-79,731,000
Inventory
—
Receivables
$32,860,000
ST Investments
—
EBIT TTM
$14,742,000
Pretax Income TTM
$9,589,000
Interest Exp TTM
$5,153,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$107,345,000
EBITDA
$18,858,000
Free Cash Flow
$11,345,375
Enterprise Value
$101,688,344
Total Cash
$20,169,000
Total Debt
$23,716,000
Shares Out
18,765,075
Trailing EPS
$0.36
Book Value
$6.84
ROE
5.6%
ROA
5.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 109,429,000 | 12,061,000 | 5,132,000 | 176,918,000 | 48,624,000 | — | 18,715,000 |
| Dec 2024 | 92,127,000 | -6,217,000 | -20,110,000 | 171,168,000 | 54,170,000 | — | 4,889,000 |
| Dec 2023 | 71,522,000 | -17,522,000 | -17,566,000 | 183,374,000 | 56,821,000 | — | -7,240,000 |
| Dec 2022 | 62,450,156 | -12,290,738 | -11,438,440 | 134,651,185 | 8,540,408 | — | 10,654,078 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$21,309,000
NetIncome TTM
$-9,124,000
OpCashFlow TTM
$0
Assets (Latest)
$171,168,000
Forward EPS
$1.09
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BCRD | BlueOne Technologies, Inc. | $98.90M | $6.90 | — |
| LUCN | Lucent, Inc. | $101.93M | $6.00 | — |
| BAER | Bridger Aerospace Group Holdings, Inc. | $109.51M | $1.90 | — |
| YOOV | Concorde International Group Ltd. | $110.16M | $0.53 | — |
| RYDE | Ryde Group Ltd | $110.74M | $0.74 | — |
News headlines (Yahoo Finance, 1h cache)
OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust
2026-06-09 12:33 · Yahoo
OptimizeRx to Participate in Upcoming Investor Conferences
2026-06-01 11:30 · Yahoo
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
2026-05-28 15:02 · Yahoo
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
2026-05-21 11:30 · Yahoo
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
2026-05-20 14:40 · Yahoo
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
2026-05-20 12:46 · Yahoo
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
2026-05-15 14:09 · Yahoo
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates
2026-05-15 11:41 · Yahoo
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
2026-05-14 19:24 · Yahoo
OptimizeRx Corp (OPRX) Q1 2026 Earnings Call Highlights: Strong AI Growth Amid Revenue Challenges
2026-05-13 05:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.